on 18 Sep 2024
Last Applicant/ Owned by
Boehringer Ingelheim International GmbH
55218 Ingelheim
DE
Serial Number
2350531 filed on 30th Jul 2024
TRIANGULAR FIGURES DESIGN
Vienna Information
26 . 3 . 4
Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant
26 . 3 . 7
Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis
26 . 3 . 24
Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée
26 . 4 . 3
Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe
26 . 4 . 4
Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis
26 . 4 . 11
Quadrilaterals containing one or more triangles or lines forming an angleQuadrilatères contenant un ou plusieurs triangles ou des lignes formant un angle
26 . 4 . 12
Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).
26 . 4 . 24
Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée
24 . 13 . 9
Crosses formed by intersecting linesCroix formées de lignes qui se coupent
24 . 13 . 25
Other crossesAutres croix
25 . 12 . 1
Surfaces or backgrounds covered with rays or radiating linesSurfaces ou fonds rayonnés
29 . 1 . 6
White, grey, silverBlanc, gris, argent
29 . 1 . 1
Red, pink, orangeRouge, rose, orangé
29 . 1 . 4
BlueBleu
Trademark usage description
pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read MoreClassification Information
Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of infectious diseases, namely viral infections.
Classification kind code
12
Mark Details
Serial Number
2350531
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 257 on 19th Sep 2024 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 18th Sep 2024 | Created |
| Submitted for opposition 31 on 18th Sep 2024 | Formalized |
| Submitted for opposition 228 on 30th Jul 2024 | International Registration |
| Submitted for opposition 30 on 30th Jul 2024 | Filed |